Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Energy

Denarius Metals stock jumps on exploration update plus more daily small cap movers

A timeline for drill results and future exploration sparked shares of Denarius Metals Corp Wednesday plus other big percentage movers on news from the small and micro cap space

4:05pm: Denarius Metals shares add to gains late day

Denarius Metals closed up 16% at $0.465, while Cabral Gold rose 17% to $0.14, Immunic finished 6% higher to $1.55, and Trillion Energy International ended up 5% at $0.40.

1:05pm: Denarius Metals, Cabral Gold shares make big gains

Denarius Metals Corp (TSXV:DSLV) shares climbed 13% to $0.45 on Wednesday after the junior explorer announced that it has received approval for a three-year extension of its Rubia Permit at the Lomero project in Spain, while noting that it expects to have its Phase 2 drilling results at Lomero available later in April and plans to continue its exploration work in Spain in 2023 with 10,000 metres (m) of drilling at its Lomero Project and 7,000m of drilling at the Toral Project.

As well, shares of Cabral Gold Inc (TSX-V:CBR) gained 17% to $0.14 as the gold junior said its Brazilian subsidiary has engaged Ausenco do Brasil Engenharia Ltda to begin a pre-feasibility study (PFS) on trial mining and leach processing of the near-surface gold-in-oxide saprolitic material at the Cuiú Cuiú project in northern Brazil.

READ: Cabral Gold commences pre-feasibility study at Cuiú Cuiú gold project in Brazil

Immunic Inc (NASDAQ:IMUX), meanwhile, reported positive data from the maintenance phase of its phase 2b CALDOSE-1 trial of lead asset vidofludimus calcium (IMU-838) in patients with moderate-to-severe ulcerative colitis (UC). Immunic stock popped 16% to $1.70 following the announcement.

And, Trillion Energy International Inc. (CSE:TCF, OTCQB:TRLEF) shares rose 9% to $0.42 on Wednesday after the natural gas producer announced the results of its January reserve report update for the SASB gas field, saying its share of proved and probable conventional natural gas reserves (P2) in the field increased 30% to 63.3 billion cubic feet (BCF) at the end of 2022.

Contact Sean at sean@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK